Literature DB >> 30630751

DNA repair as an emerging target for COPD-lung cancer overlap.

Catherine R Sears1.   

Abstract

Cigarette smoking is the leading cause of lung cancer and chronic obstructive pulmonary disease (COPD). Many of the detrimental effects of cigarette smoke have been attributed to the development of DNA damage, either directly from chemicals contained in cigarette smoke or as a product of cigarette smoke-induced inflammation and oxidative stress. In this review, we discuss the environmental, epidemiological, and physiological links between COPD and lung cancer and the likely role of DNA damage and repair in COPD and lung cancer development. We explore alterations in DNA damage repair by DNA repair proteins and pathways. We discuss emerging data supporting a key role for the DNA repair protein, xeroderma pigmentosum group C (XPC), in cigarette smoke-induced COPD and early lung cancer development. Understanding the interplay between cigarette smoke, DNA damage repair, COPD, and lung cancer may lead to prognostic tools and new, potentially targetable, pathways for lung cancer prevention and treatment.
Copyright © 2018 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cigarette smoke; Emphysema; Mutations; Nucleotide excision repair; Oxidative stress

Mesh:

Year:  2019        PMID: 30630751     DOI: 10.1016/j.resinv.2018.11.005

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  9 in total

Review 1.  Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Authors:  Brielle A Parris; Hannah E O'Farrell; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 2.  Tumor-promoting inflammation in lung cancer: A literature review.

Authors:  Gemilang Khusnurrokhman; Farah Fatma Wati
Journal:  Ann Med Surg (Lond)       Date:  2022-06-19

3.  DNA Repair Capacity for Personalizing Risk and Treatment Response - Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs).

Authors:  Nawar Al Nasrallah; Huaxin Zhou; Patricia A Smith; Catherine R Sears
Journal:  DNA Repair (Amst)       Date:  2022-01-19

Review 4.  Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.

Authors:  Nawar Al Nasrallah; Benjamin M Wiese; Catherine R Sears
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

Review 5.  Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Authors:  Thomas G Johnson; Karin Schelch; Sunali Mehta; Andrew Burgess; Glen Reid
Journal:  Front Cell Dev Biol       Date:  2019-10-01

6.  Self-DNA release and STING-dependent sensing drives inflammation to cigarette smoke in mice.

Authors:  Mégane Nascimento; Aurélie Gombault; Norinne Lacerda-Queiroz; Corinne Panek; Florence Savigny; Malak Sbeity; Manon Bourinet; Marc Le Bert; Nicolas Riteau; Bernhard Ryffel; Valérie F J Quesniaux; Isabelle Couillin
Journal:  Sci Rep       Date:  2019-10-16       Impact factor: 4.379

7.  Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer.

Authors:  Jia-Qi He; Qin Chen; Sheng-Jun Wu; De-Qin Wang; Shen-Yingjie Zhang; Song-Zhao Zhang; Rui-Lin Chen; Jia-Feng Wang; Zhen Wang; Chen-Huan Yu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

8.  Insight into the pulmonary molecular toxicity of heated tobacco products using human bronchial and alveolar mucosa models at air-liquid interface.

Authors:  Swapna Upadhyay; Koustav Ganguly; Mizanur Rahman; Martin Irmler; Micol Introna; Johannes Beckers; Lena Palmberg; Gunnar Johanson
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

9.  Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma.

Authors:  Shaopeng Zheng; Lintong Yao; Fasheng Li; Luyu Huang; Yunfang Yu; Zenan Lin; Hao Li; Jin Xia; Michael Lanuti; Haiyu Zhou
Journal:  PeerJ       Date:  2021-02-16       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.